Projects per year
Personal profile
Education
- 1998 Ph.D. Pharmacology, Massachusetts College of Pharmacy and Health Sciences
- 1996 M.S., Pharmacology, Massachusetts College of Pharmacy and Health Sciences
- 1991 B.S., School of Pharmacy, China Medical University
Experience
- 2016- Professor, Department of Clinical Pharmacy, Taipei Medical University
- 2016-2017 Associate Professor, Ph.D. Program in Drug Discovery and Development Industry, Taipei Medical University
- 2012-2016 Associate Professor, Department of Clinical Pharmacy, Taipei Medical University
- 2008-2012 Associate Professor, School of Pharmacy, Taipei Medical University
- 2002-2008 Assistant Professor, School of Pharmacy, Taipei Medical University
Research Interests
- Biochemistry of cataract, infertility and neurodegenerative diseases
- Therapeutic drug monitoring and clinical pharmacokinetics in psychiatrics and blood disorders
- Pharmaceutical care and managements
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
評估急重症就診病人營養元素缺乏型態及藥物治療成效(1/3)
Wu, T.-H. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
Application of Therapeutic Drug Monitoring and Omic Technologies to Investigate Factors Regulating Prolactin and Disease Managements
Wu, T.-H. (PI)
8/1/22 → 7/31/23
Project: A - Government Institution › b - National Science and Technology Council
-
刺蒺藜與潼蒺藜粗萃對精子活性差異與鋅鎂濃度的影響
Wu, T.-H. (PI)
7/1/21 → 2/28/22
Project: A - Government Institution › b - National Science and Technology Council
-
Effects of Lycium Barbarum Polysaccharides on Iron Overload Associated Disorders
Wu, T.-H. (PI)
8/1/20 → 7/1/21
Project: A - Government Institution › b - National Science and Technology Council
-
探討酵素基因多型性變異及生化營養指標對接受鐵螯合治療之重型海洋性貧血病人心臟鐵質沉積控制成效的影響
Wu, T.-H. (PI)
7/1/20 → 2/1/21
Project: A - Government Institution › b - National Science and Technology Council
-
Associations between paraoxonase-1 activity and therapeutic drug monitoring indicators in schizophrenia patients treated with olanzapine: A cross-sectional study
Wu, T. H., Hu, S. C., Sylfa, N., Liao, J. H., Raza, A., Chen, B. L., Chen, C. H. & Lu, M. L., 2025, (Accepted/In press) In: Journal of Psychopharmacology.Research output: Contribution to journal › Article › peer-review
-
Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction
Goh, K. K., Chen, C. Y. A., Wu, T. H., Chen, C. H. & Lu, M. L., Jul 1 2022, In: International journal of molecular sciences. 23, 13, 7092.Research output: Contribution to journal › Review article › peer-review
Open Access15 Citations (Scopus) -
Developing a Sensitive Platform to Measure 5-Methyltetrahydrofolate in Subjects with MTHFR and PON1 Gene Polymorphisms
Lu, M. L., Ku, W. C., Syifa, N., Hu, S. C., Chou, C. T., Wu, Y. H., Kuo, P. H., Chen, C. H., Chen, W. J. & Wu, T. H., Aug 2022, In: Nutrients. 14, 16, 3320.Research output: Contribution to journal › Article › peer-review
Open Access6 Citations (Scopus) -
Efficacy and safety of intermittent theta-burst stimulation in patients with schizophrenia: A meta-analysis of randomized sham-controlled trials
Goh, K. K., Chen, C. H., Wu, T. H., Chiu, Y. H. & Lu, M. L., Aug 22 2022, In: Frontiers in Pharmacology. 13, 944437.Research output: Contribution to journal › Article › peer-review
Open Access11 Citations (Scopus) -
Efficacy of N-methyl-D-aspartate receptor modulator augmentation in schizophrenia: A meta-analysis of randomised, placebo-controlled trials
Goh, K. K., Wu, T. H., Chen, C. H. & Lu, M. L., Jan 2021, In: Journal of Psychopharmacology. 35, 3, p. 236-252 17 p.Research output: Contribution to journal › Article › peer-review
31 Citations (Scopus)
Datasets
-
MOESM2 of Constructing a bilingual website with validated database for Herb and Western medicine interactions using Ginseng, Ginkgo and Dong Quai as examples
Chien, S.-K. (Contributor), Wu, C.-S. (Contributor), Hung, Y.-C. (Creator), Cheng, K.-J. (Contributor), Wu, T.-H. (Contributor), Syifa, N. (Contributor), Lo, P.-T. (Contributor), Lin, S.-Y. (Contributor), Hu, S.-C. (Creator), Chen, Y.-H. (Contributor) & Chen, C.-L. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.11293076.v1, https://doi.org/10.6084%2Fm9.figshare.11293076.v1
Dataset
-
MOESM1 of Constructing a bilingual website with validated database for Herb and Western medicine interactions using Ginseng, Ginkgo and Dong Quai as examples
Wu, C.-S. (Contributor), Chen, Y.-H. (Contributor), Chen, C.-L. (Contributor), Chien, S.-K. (Contributor), Syifa, N. (Contributor), Hung, Y.-C. (Creator), Cheng, K.-J. (Contributor), Hu, S.-C. (Creator), Lo, P.-T. (Contributor), Lin, S.-Y. (Contributor) & Wu, T.-H. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.11293073.v1, https://springernature.figshare.com/articles/MOESM1_of_Constructing_a_bilingual_website_with_validated_database_for_Herb_and_Western_medicine_interactions_using_Ginseng_Ginkgo_and_Dong_Quai_as_examples/11293073/1
Dataset
-
Efficacy of N-methyl-D-aspartate receptor modulator augmentation in schizophrenia: A meta-analysis of randomised, placebo-controlled trials
Goh, K. K. (Contributor), Wu, T.-H. (Contributor), Chen, C.-H. (Contributor) & Lu, M.-L. (Contributor), SAGE Journals, 2021
DOI: 10.25384/sage.c.5262416.v1, https://sage.figshare.com/collections/Efficacy_of_i_N_i_-methyl-_i_D_i_-aspartate_receptor_modulator_augmentation_in_schizophrenia_A_meta-analysis_of_randomised_placebo-controlled_trials/5262416/1
Dataset
-
sj-pdf-1-jop-10.1177_0269881120965937 – Supplemental material for Efficacy of N-methyl-D-aspartate receptor modulator augmentation in schizophrenia: A meta-analysis of randomised, placebo-controlled trials
Wu, T.-H. (Contributor), Lu, M.-L. (Contributor), Chen, C.-H. (Contributor) & Goh, K. K. (Contributor), SAGE Journals, 2021
DOI: 10.25384/sage.13547384.v1, https://doi.org/10.25384%2Fsage.13547384.v1
Dataset